Facebook Icon Print Created with Sketch. Twitter Icon Created with Sketch. Created with Sketch. LinkedIn Icon Green Check Icon Created with Sketch. YouTube Icon Right Arrow Icon Mobile Menu Icon Chevron Right Icon Phone Icon Health Study Area: AutoImmune Disease Health Study Area: Blood Cancer Health Study Area: Cardiovascular Disease Health Study Area: Fibrosis Health Study Area: Gastrointestinal Cancer Health Study Area: Genitourinary Health Study Area: Head and Neck Cancer Health Study Area: Lung Cancer Health Study Area: Melanoma Health Study Area: Women's Cancer For Caregivers For Clinicians Communities FAQs For Parents For Patients Chevron Icon Bookmark Icon Map Icon Share Icon Direction Arrow Icon Direction Arrow Icon Page Icon Location Icon Search Icon External Link Icon Help Icon Error Icon Glossary Email Icon Gender Both Gender Male Gender Female Created with Sketch. Created with Sketch.

Inicie sesión o únase ahora para utilizar esta función

Recruiting

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants - IM101-675

Actualizada: 16 February, 2018   |   ClinicalTrials.gov

Imprimir Resumen

¿CONSIDERANDO ESTE ENSAYO?
Imprima esta página y la guía de ensayo para ayudarlo a hablar con su médico.
Use la guía de ensayo para navegar el proceso de participación en un ensayo clínico. Comprenda los factores clave que debe tener en cuenta antes de tomar una decisión y haga preguntas a su equipo de atención médica.
Imprime esta página IM101-675
Descargar la guía

SELECCIONE EL IDIOMA

Detalles del ensayo

  • Género(s)

  • 18+

    Rango de edad

  • 1

    Ubicación(es)

  • Recruiting

Opciones de tratamiento

Brazos del estudio
INTERVENCIÓN ASIGNADA
Adults initiating abatacept for PsA after one failed TNFi
Otros: Non-interventional
Biologic-naive adults initiating abatacept for PsA
Otros: Non-interventional

Criterios clave de elegibilidad

Inclusion Criteria: - Patients 18 years of age at enrollment - Patients who signed an informed consent - Patients diagnosed with PsA as per the criteria of the Classification of Psoriatic Arthritis (CASPAR) Study Group17 - Patients naïve of abatacept and who at their physician's discretion initiate abatacept - Patients meeting criteria for abatacept treatment for PsA as specified in the German label Exclusion Criteria: - Patients who are currently included in any interventional clinical trial in PsA/RA Other protocol defined criteria inclusion/exclusion criteria could apply

¿Tiene alguna pregunta? Llame 855-907-3286 o Envíenos un correo electrónico

¿Tiene alguna pregunta?
Llame 855-907-3286 o Envíenos un correo electrónico